215 related articles for article (PubMed ID: 32821253)
1. Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis.
Fu W; Wang K; Yan S; Wang X; Tang B; Chang J; Wang R; Wu T
Dose Response; 2020; 18(3):1559325820942065. PubMed ID: 32821253
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Qi F; Xu Y; Zheng Y; Li X; Gao Y
Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis.
Zhang H; Ren D; Jin X; Wu H
Cancer Cell Int; 2020; 20():462. PubMed ID: 32982584
[TBL] [Abstract][Full Text] [Related]
4. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
Nie D; Zhang L; Wang C; Guo Q; Mao X
Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer.
Zhang Y; Chen S; Chen H; Li W
Cancer Med; 2023 Jan; 12(1):38-48. PubMed ID: 35702873
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis.
Tan D; Li J; Lin T; Tan P; Zhang J; Xiong Q; Jiang J; Li Y; Zhang P; Wei Q
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362488
[TBL] [Abstract][Full Text] [Related]
7. A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma.
Tong T; Guan Y; Xiong H; Wang L; Pang J
Front Oncol; 2020; 10():1541. PubMed ID: 33042799
[No Abstract] [Full Text] [Related]
8. Prognostic value of preoperative modified Glasgow prognostic score in surgical non-small cell lung cancer: A meta-analysis.
Yang C; Ren G; Yang Q
Front Surg; 2022; 9():1094973. PubMed ID: 36700011
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients.
Wu D; Wang X; Shi G; Sun H; Ge G
Aging (Albany NY); 2021 Jan; 13(1):1410-1421. PubMed ID: 33406501
[TBL] [Abstract][Full Text] [Related]
10. Predicting outcomes of Lung Cancer using the modified glasgow prognostic score: A systematic review and meta-analysis.
Min Y; Li X; Chen H; Xu Y; Lan G
Pak J Med Sci; 2024; 40(3Part-II):534-543. PubMed ID: 38356845
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Pretreatment Glasgow Prognostic Score/Modified Glasgow Prognostic Score in Ovarian Cancer: A Systematic Review and Meta-Analysis.
Xu S; Song L; Liu X
Nutr Cancer; 2022; 74(6):1968-1975. PubMed ID: 34549675
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
Jin J; Hu K; Zhou Y; Li W
PLoS One; 2017; 12(9):e0184412. PubMed ID: 28886134
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis.
Xie Y; Li H; Hu Y
Medicine (Baltimore); 2023 Nov; 102(45):e35962. PubMed ID: 37960803
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.
Lu X; Guo W; Xu W; Zhang X; Shi Z; Zheng L; Zhao W
Cancer Manag Res; 2019; 11():229-249. PubMed ID: 30636896
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis.
Zhou Y; Liu Z; Cheng Y; Li J; Fu W
J Gastrointest Surg; 2024 Apr; 28(4):559-565. PubMed ID: 38583910
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis.
Wang Y; Chen L; Wu Y; Li P; Che G
Nutr Cancer; 2020; 72(7):1146-1154. PubMed ID: 31617767
[No Abstract] [Full Text] [Related]
18. Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis.
Wu TH; Tsai YT; Chen KY; Yap WK; Luan CW
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674837
[TBL] [Abstract][Full Text] [Related]
19. Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: a systematic review and meta-analysis.
Hu X; Wang Y; Yang WX; Dou WC; Shao YX; Li X
Cancer Manag Res; 2019; 11():6163-6173. PubMed ID: 31308752
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer.
Kimura S; D' Andrea D; Soria F; Foerster B; Abufaraj M; Vartolomei MD; Iwata T; Karakiewicz PI; Rink M; Gust KM; Egawa S; Shariat SF
Urol Oncol; 2019 Mar; 37(3):179.e19-179.e28. PubMed ID: 30580906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
